Thermo Fisher Scientific Inc (NYSE:TMO)
| 626.14 Delayed Data As of Dec 01 |  -6.69 / -1.06%Today’s Change | 433.52 Today|||52-Week Range 666.65 | +34.43% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Quarter Trend | |||||
|---|---|---|---|---|---|---|
| Quarter 3 2018 | Quarter 4 2018 | Quarter 1 2019 | Quarter 2 2019 | |||
| Revenue and Income | Net Revenues | 5.9B | 6.5B | 6.1B | 6.3B | |
| Cost of Goods Sold | 2.7B | 3.3B | 2.9B | 2.9B | ||
| Depreciation And Amortization | 563.0M | 558.0M | 555.0M | 571.0M | ||
| Operating Expenses | Gross Income | 2.6B | 2.6B | 2.7B | 2.8B | |
| General Expenses | 1.7B | 1.4B | 1.7B | 1.7B | ||
| Other Operating Expenses | 31.0M | 32.0M | 27.0M | 26.0M | ||
| Research And Development | 240.0M | 251.0M | 248.0M | 246.0M | ||
| Total Operating Expenses | 5.0B | 5.3B | 5.2B | 5.3B | ||
| Non-Operating Expenses | Operating Income | 881.0M | 1.2B | 946.0M | 1.1B | |
| Extraordinary Credit | 39.0M | 3.0M | 20.0M | 443.0M | ||
| Extraordinary Charge | -1.0M | -43.0M | -28.0M | -13.0M | ||
| Interest Expense On Debt | 162.0M | 172.0M | 189.0M | 181.0M | ||
| Other Expenses | 12.0M | -8.0M | 1.0M | 28.0M | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | 810.0M | 1.0B | 817.0M | 1.4B | |
| Income Taxes | -101.0M | -114.0M | -2.0M | -274.0M | ||
| Net Income | 709.0M | 898.0M | 815.0M | 1.1B | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 402.0M | 402.0M | 400.0M | 400.0M | |
| Shares To Calculate EPS Diluted | 406.0M | 405.0M | 403.0M | 403.0M | ||
| Earnings Per Share | EPS | $1.75 | $2.22 | $2.02 | $2.77 | |
| EPS Diluted | $1.75 | $2.22 | $2.02 | $2.78 | ||
